Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration

Table 1

Relationship between cytopathologic evaluation and KRAS point mutation in specimens of pancreatic cancer (62 cases) obtained by EUS-FXA; citation from [7].

	Cytology	KRAS point mutation positive
No malignancy	4	2 (50%)
Suspicion of malignancy	7	5 (71%)
Malignancy	51	39 (76%)
Total	62	46